{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:55:34Z","timestamp":1784141734810,"version":"3.55.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0187729","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T13:33:48Z","timestamp":1510234428000},"page":"e0187729","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertension"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7011-0422","authenticated-orcid":true,"given":"Timo P.","family":"Hiltunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni M.","family":"Rimpel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Mohney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Stirdivant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo K.","family":"Kontula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"SS Lim","year":"2012","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(14)61468-9","article-title":"Hypertension","volume":"386","author":"NR Poulter","year":"2015","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988\u20132008","volume":"303","author":"BM Egan","year":"2010","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/eurheartj\/ehr080","article-title":"Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study","volume":"32","author":"JR Banegas","year":"2011","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/eurheartj\/ehs455","article-title":"Genes for blood pressure: an opportunity to understand hypertension","volume":"34","author":"GB Ehret","year":"2013","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/CIRCRESAHA.116.303647","article-title":"Genetic and molecular aspects of hypertension","volume":"116","author":"S Padmanabhan","year":"2015","journal-title":"Circ Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s11906-015-0586-5","article-title":"Pharmacogenomics of hypertension and heart disease","volume":"17","author":"MJ Arwood","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrneph.2015.176","article-title":"Hypertension pharmacogenomics: in search of personalized treatment approaches","volume":"12","author":"RM Cooper-DeHoff","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/HYP.0b013e31825b30f8","article-title":"Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker","volume":"59","author":"ST Turner","year":"2012","journal-title":"Hypertension"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/HYPERTENSIONAHA.111.00436","article-title":"Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide","volume":"62","author":"ST Turner","year":"2013","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2217\/pgs.13.161","article-title":"Genome-wide response to antihypertensive medication using home blood pressure measurements: a pilot study nested within the HOMED-BP study","volume":"14","author":"K Kamide","year":"2013","journal-title":"Pharmacogenomics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2217\/pgs.14.119","article-title":"Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study","volume":"15","author":"F Frau","year":"2014","journal-title":"Pharmacogenomics"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e001521","DOI":"10.1161\/JAHA.114.001521","article-title":"Pharmacogenomics of hypertension: a genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs","volume":"4","author":"TP Hiltunen","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/HJH.0000000000000541","article-title":"TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives","volume":"33","author":"M Chittani","year":"2015","journal-title":"J Hypertens"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1097\/HJH.0000000000000714","article-title":"PTPRD gene associated with blood pressure response to atenolol and resistant hypertension","volume":"33","author":"Y Gong","year":"2015","journal-title":"J Hypertens"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.116.08267","article-title":"Genome-wide and gene-based meta-analyses identify novel loci influencing blood pressure response to hydrochlorothiazide","volume":"69","author":"E Salvi","year":"2017","journal-title":"Hypertension"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/HJH.0000000000000168","article-title":"Metabolomics in hypertension","volume":"32","author":"SB Nikolic","year":"2014","journal-title":"J Hypertens"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e57639","DOI":"10.1371\/journal.pone.0057639","article-title":"Pharmacometabolomics reveals racial differences in response to atenolol treatment","volume":"8","author":"WR Wikoff","year":"2013","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/psp4.12017","article-title":"Pharmacometabolomic assessments of atenolol and hydrochlorothiazide treatment reveal novel drug response phenotypes","volume":"4","author":"DM Rotroff","year":"2015","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/HYPERTENSIONAHA.116.07328","article-title":"A genetic response score for hydrochlorothiazide use: insights from genomics and metabolomics integration","volume":"68","author":"MH Shahin","year":"2016","journal-title":"Hypertension"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.115.05544","article-title":"Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate","volume":"66","author":"C Menni","year":"2015","journal-title":"Hypertension"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e1600800","DOI":"10.1126\/sciadv.1600800","article-title":"Loss-of-function variants influence the human serum metabolome","volume":"2","author":"B Yu","year":"2016","journal-title":"Sci Adv"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjhyper.2006.09.006","article-title":"Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study)","volume":"20","author":"TP Hiltunen","year":"2007","journal-title":"Am J Hypertens"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/HJH.0b013e3282fcc37f","article-title":"Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study","volume":"26","author":"T Suonsyrja","year":"2008","journal-title":"J Hypertens"},{"key":"ref25","first-page":"132","article-title":"High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high throughput profiling metabolomics","volume":"4","author":"AM Evans","year":"2014","journal-title":"Metabolomics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1758-2946-2-9","article-title":"Organization of GC\/MS and LC\/MS metabolomics data into chemical libraries","volume":"2","author":"CD Dehaven","year":"2010","journal-title":"J Cheminform"},{"key":"ref27","first-page":"167","article-title":"Metabolomics","author":"CD DeHaven","year":"2012"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF03261931","article-title":"Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects","volume":"51","author":"SE Reuter","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","article-title":"Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease","volume":"163","author":"SH Shah","year":"2012","journal-title":"Am Heart J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e000542","DOI":"10.1161\/JAHA.113.000542","article-title":"A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients","volume":"2","author":"S Kalim","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.atherosclerosis.2013.10.029","article-title":"Metabolomics signature improves the prediction of cardiovascular events in elderly subjects","volume":"232","author":"S Rizza","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.drudis.2010.03.014","article-title":"The therapeutic prospects of using L-carnitine to manage hypertension-related organ damage","volume":"15","author":"A Mate","year":"2010","journal-title":"Drug Discov Today"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11745-012-3732-8","article-title":"L-carnitine and long-chain acylcarnitines are positively correlated with ambulatory blood pressure in humans: the SABPA study","volume":"48","author":"CM Mels","year":"2013","journal-title":"Lipids"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/01.AOG.0000125699.60416.03","article-title":"Increased plasma carnitine concentrations in preeclampsia","volume":"103","author":"IG Thiele","year":"2004","journal-title":"Obstet Gynecol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance?","volume":"62","author":"MG Schooneman","year":"2013","journal-title":"Diabetes"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1210\/er.2015-1036","article-title":"The regulation of steroid action by sulfation and desulfation","volume":"36","author":"JW Mueller","year":"2015","journal-title":"Endocr Rev"},{"key":"ref37","article-title":"The role of sulfated steroid hormones in reproductive processes","author":"J Geyer","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref38","first-page":"61","article-title":"Treatment of hypertension with hydrochlorothiazide and spironolactone","volume":"101","author":"RI Ogilvie","year":"1969","journal-title":"Can Med Assoc J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Z Wang","year":"2007","journal-title":"Nat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1373\/clinchem.2011.163188","article-title":"Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis","volume":"57","author":"S Jaisson","year":"2011","journal-title":"Clin Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e004700","DOI":"10.1161\/JAHA.116.004700","article-title":"Cyanate-impaired angiogenesis: association with poor coronary collateral growth in patients with stable angina and chronic total occlusion","volume":"5","author":"JT Sun","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2217\/pgs-2016-0204","article-title":"Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responses","volume":"18","author":"JM Rimpel\u00e4","year":"2017","journal-title":"Pharmacogenomics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0187729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T09:01:54Z","timestamp":1540285314000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0187729"}},"subtitle":[],"editor":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0187729","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]}}}